October 28, 2019 — Nearly two years of real-world outcomes data on Abiomed’s Impella RP heart pump shows that when ...
Investigators at the University of Arizona Steele Children's Research Center are leading a statewide study as part of a national effort to conduct population-based surveillance of congenital heart defects across the life span, thanks to funding from the U.S. Centers for Disease Control and Prevention (CDC).
LivaNova PLC announced the publication of a new study in Neurology, which suggests that chronic epilepsy may be associated with key measures of sudden cardiac death risk. This is the third in a series of studies to evaluate cardiac electrical instability in patients with chronic epilepsy, but the first to compare the cardiac impact of the disease among patients with chronic epilepsy to those who are newly diagnosed.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Proactive administration of amiodarone to patients recovering from a common heart surgery shows promise in preventing postoperative atrial fibrillation, a serious and expensive complication with potential long-term consequences.
BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable Introducer Sheath for introducing various cardiovascular catheters into the heart, including via the left side of the heart through the interatrial septum. The product became available in late September.
October 22, 2019 — Drinking small amounts of alcohol frequently is linked with a higher likelihood of atrial ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 22, 2019 — Atrial fibrillation is the most common heart arrhythmia in humans. This condition increases the risk ...
October 22, 2019 — OmniVision Technologies Inc. announced that its OV6948 camera module is the winner of the Guinness ...
Sunil Rao, M.D., chief of cardiology, Durham VA Health System and a professor at Duke University, and Prashant Kaul, M.D., director of the cath lab, Piedmont, Atlanta,
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Elevated left ventricular mass, known as left-ventricular hypertrophy, is a stronger predictor of coronary artery disease-related death and heart failure than coronary artery calcium score, according to a new study published in the journal Radiology.
Cardiovascular Systems Inc. recently announced U.S. Food and Drug Administration (FDA) premarket approval (PMA) of the new ViperWire Advance Coronary Guide Wire with Flex Tip (ViperWire Advance with Flex Tip).
October 21, 2019 – The U.S. Food and Drug Administration (FDA) has granted market clearance for AstraZeneca's ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Canon Medical Systems USA Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance on its Advanced Intelligent Clear-IQ Engine (AiCE) for the Aquilion Precision computed tomography (CT) system. The clearance further expands access to Canon’s new deep convolutional neural network (DCNN) image reconstruction technology. This technology, now available on both the Aquilion Precision and Aquilion One/Genesis Edition premium CT systems, uses a deep learning algorithm to differentiate signal from noise so that it can suppress noise while enhancing signal, forging a new frontier for CT image reconstruction.
An algorithm developed by faculty at The University of Texas Health Science Center at Houston (UTHealth) can help physicians outside of major stroke treatment centers assess whether a patient suffering from ischemic stroke would benefit from an endovascular procedure to remove a clot blocking an artery.
Robocath recently announced the success of its first two coronary angioplasties performed with assistance from its R-One robotic platform. The procedures were performed in France at Rouen University Hospital by Prof. Eric Durand and Prof. Remi Sabatier and at Clinique Pasteur in Toulouse by Jean Fajadet, M.D.